Status:
UNKNOWN
Group ACT for CD Pain- a Feasibility Study
Lead Sponsor:
King's College London
Collaborating Sponsors:
Guy's and St Thomas' NHS Foundation Trust
Conditions:
Chronic Pain
Crohn Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pain is a common symptom of inflammatory bowel disease (IBD) and has a significant impact on patient quality of life. Pain will frequently be the presenting complaint and is experienced throughout the...
Detailed Description
Aims: This study aims to assess the feasibility of ACT for reducing the impact of abdominal pain and its associated psychological burden in people with Crohn's disease (CD). The study will investigat...
Eligibility Criteria
Inclusion
- Established diagnosis of CD according to clinical notes for a minimum of 6 months
- Moderate pain, defined as mean score ≥4/10 on both pain severity and pain interference questions the Brief Pain Inventory (BPI) - a validated cut-off to define moderate pain
- Duration of pain of at least 3 months
- No changes to CD medication made for the previous 2 months
Exclusion
- Diagnosis of ulcerative colitis or indeterminate colitis
- Known diagnosis of dementia/psychosis or expressing active suicidal ideation on clinical assessment
- Currently undergoing other psychological therapy
- Primary source of pain is non-abdominal
- Non-fluency in verbal English
- Pain is identified as a part of acute flare where immediate change in medical treatment is more appropriate
Key Trial Info
Start Date :
January 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05418062
Start Date
January 11 2023
End Date
February 1 2024
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Natalie Watson
London, United Kingdom, SE1 8WA